StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

AXIM Biotechnologies's operating cash flow for the twelve months ending Jun 30, 2024 was -$759.00K. For fiscal 2023 it was -$1.03M. The highest annual figure on record is $21.11K in fiscal 2012.

Annual operating cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$1.03M–
FY2022Dec 31, 2022-$2.04M–
FY2021Dec 31, 2021-$2.49M–
FY2020Dec 31, 2020-$3.22M–
FY2019Dec 31, 2019-$5.04M–
FY2018Dec 31, 2018-$4.85M–
FY2017Dec 31, 2017-$3.08M–
FY2016Dec 31, 2016-$1.29M–
FY2015Dec 31, 2015-$1.54M–
FY2014Dec 31, 2014-$339.00K–
FY2013Dec 31, 2013-$33.02K-256.4%
FY2012Dec 31, 2012$21.11K+422.7%
FY2011Dec 31, 2011$4.04K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2024Jun 30, 2024-$261.54K–
Q1 FY2024Mar 31, 2024-$252.51K–
Q4 FY2023Dec 31, 2023$19.56K–
Q3 FY2023Sep 30, 2023-$264.50K–
Q2 FY2023Jun 30, 2023-$643.59K–
Q1 FY2023Mar 31, 2023-$141.96K–
Q4 FY2022Dec 31, 2022-$315.51K–
Q3 FY2022Sep 30, 2022-$321.23K–
Q2 FY2022Jun 30, 2022-$703.88K–
Q1 FY2022Mar 31, 2022-$703.72K–
Q4 FY2021Dec 31, 2021-$792.93K–
Q3 FY2021Sep 30, 2021-$532.84K–
Q2 FY2021Jun 30, 2021-$595.53K–
Q1 FY2021Mar 31, 2021-$565.46K–
Q4 FY2020Dec 31, 2020-$614.92K–
Q3 FY2020Sep 30, 2020-$790.17K–
Q2 FY2020Jun 30, 2020-$737.10K–
Q1 FY2020Mar 31, 2020-$1.07M–
Q4 FY2019Dec 31, 2019-$1.41M–
Q3 FY2019Sep 30, 2019-$1.75M–
Q2 FY2019Jun 30, 2019-$1.15M–
Q1 FY2019Mar 31, 2019-$728.55K–
Q4 FY2018Dec 31, 2018-$1.04M–
Q3 FY2018Sep 30, 2018-$1.05M–
Q2 FY2018Jun 30, 2018-$1.59M–
Q1 FY2018Mar 31, 2018-$1.16M–
Q4 FY2017Dec 31, 2017-$1.02M–
Q3 FY2017Sep 30, 2017-$1.02M–
Q2 FY2017Jun 30, 2017-$468.61K–
Q1 FY2017Mar 31, 2017-$580.92K–
Q4 FY2016Dec 31, 2016-$532.45K–
Q3 FY2016Sep 30, 2016-$216.14K–
Q2 FY2016Jun 30, 2016-$352.36K–
Q1 FY2016Mar 31, 2016-$193.20K–
Q4 FY2015Dec 31, 2015-$418.80K–
Q3 FY2015Sep 30, 2015-$490.80K–
Q2 FY2015Jun 30, 2015-$163.70K–
Q1 FY2015Mar 31, 2015-$465.87K–
Q4 FY2014Dec 31, 2014-$288.68K–
Q3 FY2014Sep 30, 2014-$50.03K–

More AXIM Biotechnologies figures

See a number that looks wrong?